Results 191 to 200 of about 244,635 (318)

A case of transformation of Waldenström's Macroglobulinemia to diffuse large B cell lymphoma. [PDF]

Oxf Med Case Reports
Ali MB, Kline K.
europepmc   +1 more source

Rationally designed BCL6 inhibitors target activated B cell diffuse large B cell lymphoma.

Journal of Clinical Investigation, 2016
Mariano G. Cárdenas, Wenbo Yu, W. Béguelin, Matt Teater, H. Geng, R. Goldstein, E. Oswald, K. Hatzi, S. Yang, Joanna Cohen, R. Shaknovich, K. Vanommeslaeghe, Huimin Cheng, Dongdong Liang, H. Cho, Joshua M. Abbott, W. Tam, W. Du, J. Leonard, O. Elemento, L. Cerchietti, T. Cierpicki, F. Xue, Alexander D. MacKerell, A. Melnick   +24 more
semanticscholar   +1 more source

Treatment options for immune‐related adverse events associated with immune checkpoint inhibitors

British Journal of Pharmacology, EarlyView.
Abstract The immunotherapy revolution with the use of immune checkpoint inhibitors (ICIs) started with the clinical use of the first ICI, ipilimumab, in 2011. Since then, the field of ICI therapy has rapidly expanded — with the FDA approval of 10 different ICI drugs so far and their incorporation into the therapeutic regimens of a range of malignancies.
Yu Hua Chen, Tamás Kovács, Péter Ferdinandy, Zoltán V. Varga   +3 more
wiley   +1 more source

When the Heart Is the Target: Case of Primary Pericardial Diffuse Large B-Cell Lymphoma Presenting With Tamponade. [PDF]

Case Rep Oncol Med
Bawwab A, Khatib L, Albliwi MAS, Yang L, Zhao PJ.   +4 more
europepmc   +1 more source

From Genomic and Epigenomic Maps to Medicines in Adult T‐Cell Leukemia/Lymphoma

Cancer Science, EarlyView.
ABSTRACT Adult T‐cell leukemia/lymphoma (ATL) is an aggressive and refractory hematologic malignancy that is caused by human T‐cell leukemia virus type‐1 (HTLV‐1) retrovirus. ATL results from a combination of viral latency and the accumulation of abnormalities throughout the genome, epigenome, transcriptome, and signaling pathways.
Kako Suzuki, Makoto Yamagishi
wiley   +1 more source

Chemotherapy-refractory diffuse large B-cell lymphoma and indolent B-cell malignancies can be effectively treated with autologous T cells expressing an anti-CD19 chimeric antigen receptor.

Journal of Clinical Oncology, 2015
J. Kochenderfer, M. Dudley, Sadik H. Kassim, R. Somerville, R. O. Carpenter, M. Stetler-Stevenson, J. Yang, G. Phan, M. Hughes, R. Sherry, M. Raffeld, Steven R. Feldman, Lily Lu, Yong F Li, L. Ngo, A. Goy, T. Feldman, D. Spaner, Michael L. Wang, Clara C. Chen, S. Kranick, A. Nath, Debbie-Ann N. Nathan, K. Morton, M. A. Toomey, S. Rosenberg   +25 more
semanticscholar   +1 more source

Impact of Achieving Progression‐Free Survival 24 on Subsequent Overall Survival in Diffuse Large B‐Cell Lymphoma Patients

Cancer Science, EarlyView.
The OS for patients after achieving PFS24 or PFS60 was not markedly different from that of the age‐, sex‐, and calendar period‐matched Japanese general population (PFS24: standardized mortality ratio [SMR] 1.29, 95% confidence interval [CI] 0.72–2.12, p = 0.39; PFS60: SMR 1.43, 95% CI 0.47–3.33, p = 0.55).
Ayumi Fujimoto, Wataru Munakata, Gakuto Ogawa, Ryunosuke Machida, Tomotaka Suzuki, Kazuyuki Shimada, Tsutomu Kobayashi, Ken Ohmachi, Tomohiro Kinoshita, Kiyoshi Ando, Dai Maruyama, Hirokazu Nagai   +11 more
wiley   +1 more source

Clinical Warburg Effect in a primary cutaneous lymphoma. [PDF]

Clin Hematol Int
Martins F, Fontinha G, Magalhães J, Cardoso JC, Calvão J.   +4 more
europepmc   +1 more source

Tafasitamab as Monotherapy or in Combination in Japanese Patients With B‐Cell Non‐Hodgkin Lymphoma: Results From the Phase 1b J‐MIND Study

Cancer Science, EarlyView.
J‐MIND evaluated the safety and tolerability of tafasitamab, a CD19‐targeting monoclonal antibody, alone or in combination with other therapies in Japanese patients with B‐cell non‐Hodgkin lymphoma (NHL). Most common treatment‐emergent adverse events across all groups were hematological, and no serious tafasitamab treatment‐related or fatal adverse ...
Koji Izutsu, Noriko Fukuhara, Junichiro Yuda, Youko Suehiro, Shigeru Kusumoto, Marie‐Laure Casadebaig, Kazumi Suzukawa, Kentaro Fukushima   +7 more
wiley   +1 more source

Diffuse large B-cell lymphoma with intussusception in adults: a case report and literature review. [PDF]

Front Med (Lausanne)
He K, Cai S, Xie F, Pan Q, Liu Y, Li Y, Lin X.   +6 more
europepmc   +1 more source